different presentation of multiple myeloma in bone marrow
play

J Cancer Sci Clin Ther 2018; 2 (4): 089-091 DOI: 10.26502/jcsct.5079011 Case Report Different Presentation of Multiple Myeloma in Bone Marrow Aspiration Sevtap Karaman 1* , Mehmet Ali Erkurt 2 , rfan K uku 3 , Emin Kaya 4 , Aye Nuransoy

0 downloads 1 Views 186 KB Size Report
  1. J Cancer Sci Clin Ther 2018; 2 (4): 089-091 DOI: 10.26502/jcsct.5079011 Case Report Different Presentation of Multiple Myeloma in Bone Marrow Aspiration Sevtap Karaman 1* , Mehmet Ali Erkurt 2 , İrfan K uku 3 , Emin Kaya 4 , Ayşe Nuransoy Cengiz 1 , Hasan Esat Yildirim 1 1 İnönü üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı , Malatya, Turkey 2 İnönü üniversitesi Tıp Fakültesi İç Hastalıkları, Hematolojı Bilim Dalı, Malatya , Turkey * Corresponding Author: Dr. Sevtap Karaman, İnönü üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Malatya, Turkey, E-mail: drsevtapkaraman@gmail.com Received: 25 October 2018; Accepted: 09 November 2018; Published: 15 November 2018 Abstract Multiple myeloma (MM) is a malign hematologıc disorder characterized by malign proliferation of plasma cells. Bone marrow examination are necessary for diagnosis, management of disease and prognosis. There are many case of literature related that amounts and morphology of cells in bone marrow biopsy and bone marrow aspiration have an impact on survival, classification and critical management of disease. We presented a rare case of myeloma with plasma cells clustered in the bone marrow aspiration. Keywords: Multiple myeloma; Plasma cells; Bone marrow 1. Introduction Multiple myeloma (MM) is a plasma cells dyscrasia. There are also multiple myeloma varieties that do not produce monoclonal immunoglobulins, although ıt is characterized by a proliferation of monoclonal immunoglobulin producing plasma cells. It is more frequently seen in men between sixth and seventh decades of life. Disease occurs in many ways such as persistent pain in bone, fewer, fatigue, renal dysfunction, hypercalcemia or rarely with primary systemic amyloidosis. Osteolytic lesions osteopenia, and/or skeletal complications could be seen up to 80% of patients because of the neoplastic plasma cells which proliferate in the bone marrow [1]. MM diagnose is often suspected. Monoclonal protein in blood or urine important for diagnose. Bone pain or lytic lesions, although low serum albumin level increased serum total protein, unexplained anemia, symptomatic or non-symptomatic hypercalcemia or acute renal failure could be symptoms [2]. Amyloidosis is a rare disease which consist of primary, secondary and famılıal amyloidosis. Primary systemic amyloidosis (AL amyloidosis) always associated with plasma cell dyscrasia. Amyloid deposition localized multiple organs which contains like heart, kidneys, lung, tongue, Journal of Cancer Science and Clinical Therapeutics 89

  2. J Cancer Sci Clin Ther 2018; 2 (4): 089-091 DOI: 10.26502/jcsct.5079011 salıvary gland, skin, periartıcular ti ssue. Multiple myleoma is a common cause of amyloidosis. In this case, our patient presented specific cardiac amyloidosis and proteinuria depended on renal involvement. When clinical suspect occur, the mo st important step is prove the clonal bone marrow plasma cells ≥10 percent or biopsy-proven bony or soft tissue plasmacytoma [3]. In the bone marrow aspiration, plasma cells can be seen in mature, immature, anaplastic forms and in various morphological forms. Our patient was diagnosed with cardiac amyloidosis while investigating the etiology of pleural effusion. Also suspected renal involvement in the patient with proteinuria. In this report we present a case of different presentation of multiple myeloma. We underline interesting, grouped plasma cells in bone marrow aspiration [Figure 1]. Figure 1: Clustered plasma cells in bone marrow aspiration. 2. Case Report A 60 years old male patient presented with dyspnea. In the detailed system inquiries, there are inappetence and 10 weight loss in 3 months. Physical examination revealed cachectic and pale appearance. Also bilateral lung basal sounds decreased and pretibial edema was present in both legs. Bilateral pleural effusion, anemia and 4, 5 gr proteinuria in the spot urine was detected. Samples were taken from the pleural effusion and evaluated as borderline transudate and suspicious malign cytology. At the same time, echocardiography was planned and cardiac amyloidosis image taken. Then with the clinical suspect of MM either, the immunofixation of the serum and 24 hour urine were studied and or bone marrow aspiration and biopsy was planned. In the bone marrow aspiration was interesting about its clustering plasma cells view. 3. Discussion The amount of plasma cells in the bone marrow in multiple myeloma ranges from 10% to 90%. The morphology of these cells is also different. Plasma cells can be mature morphology or intermediate, immature or plasmablastic variant. This is important for the stage and management of the disease. There are multiple cases of myeloma whıch containing plasma cells showing several different morphologies such as Auer rod like inclusions [4], int racytoplasmic pınk inclusions [5] , spindle shaped cells. But there is no publication on clustered positioning of plasma cells in multiple myeloma and the prognostıc value of this morphologic varıant is currently unclear. Unfortunately the patient of our case died one week after diagnosis. Therefore we could not monitor and treat the Journal of Cancer Science and Clinical Therapeutics 90

  3. J Cancer Sci Clin Ther 2018; 2 (4): 089-091 DOI: 10.26502/jcsct.5079011 patient and observe the response to treatment. In this report, we wanted to remind different forms of clinical presentation of multiple myeloma and to draw attention to grouped plasma cells in bone marrow aspiration. References 1. Sonmez M, Akagun T, Topbas M, et al. Effect of pathologic fractures on survival in multiple myeloma patients: a case control study. J Exp Clin Cancer Res 27 (2008): 11. 2. Kariyawasan CC, Hughes DA, Jayatillake MM, et al. Multiple myeloma: causes and consequences of delay in diagnosis. QJM 100 (2007): 635. 3. Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15 (2014): 538. 4. Hutter G, Nowak D, Blau IW, et al. Auer rod-like intracytoplasmic inclusions in multiple myeloma. A case report and review of the literature. Int J Lab Hematol 31 (2009): 236-240. Juan Zhang, Mingyong Li, Xianyong Jiang, et al. Large Pink Inclusions in Multiple Myeloma Cells. 5. Journal of Blood Disorders, Symptoms and Treatments 2017. Citation: Sevtap Karaman, Mehmet Ali Erkurt, İrfan kuku, Emin Kaya, Ayse Nuransoy Cengiz, Hasan Esat Yildirim. Different Presentation of Multiple Myeloma in Bone Marrow Aspiration. Journal of Cancer Science and Clinical Therapeutics 2 (2018): 89-91. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license 4.0 Journal of Cancer Science and Clinical Therapeutics 91

Recommend Documents


what is bone marrow
What is bone marrow? What does bone

Myelodysplastic Syndrome: Let s build a definition Myelo bone marrow What

normal bone marrow morphology
Normal Bone Marrow Morphology Emily

Normal Bone Marrow Morphology Emily Glynn University of Washington

marrow cellution
Marrow Cellution Autologous Bone

Marrow Cellution Autologous Bone Marrow Aspiration & Cancellous Bone

marrow cells bone marrow failure
Marrow Cells Bone Marrow Failure

Marrow Cells Bone Marrow Failure Marrow stem cells are the cells from

marrow cellution
Marrow Cellution Autologous Bone

Marrow Cellution Autologous Bone Marrow Aspiration & Cancellous Bone Graft

bone marrow
BONE MARROW AND BLOOD July 2016 Dr

UNDERSTANDING BONE MARROW AND BLOOD July 2016 Dr Ana Carvalhosa

multiple myeloma relapsed and refractory
Multiple Myeloma: Relapsed and

Multiple Myeloma: Relapsed and Refractory David H. Vesole, MD, PhD, FACP

approaches for relapsed refractory multiple myeloma
Approaches for Relapsed &

Approaches for Relapsed & Refractory Multiple Myeloma Robert Z. Orlowski,

defenses against disease origin of immune cells
Defenses Against Disease Origin

Defenses Against Disease Origin of Immune Cells Bone marrow stem

leukemia
Leukemia Components of the bone marrow

Leukemia Every 4 minutes a new person is diagnosed Every 10 minutes somebody

label extension
Label Extension Daniel P. Judge, M.D.

Long-term safety and efficacy of AG10 in ATTR-CM: Phase 2 Open Label

to fold or to misfold what is the problem
To Fold or to Misfold: What is the

To Fold or to Misfold: What is the Problem? (Molecular Origami) Sheena E

progress in detecting prions and diagnosing prion diseases
Progress in detecting prions and

Progress in detecting prions and diagnosing prion diseases Byron Caughey

variable presentation and pathologic overlap of rare
Variable Presentation and Pathologic

Variable Presentation and Pathologic Overlap of Rare Neuromuscular Condition

a rare nasopharyngeal presentation
A Rare Nasopharyngeal Presentation The

Case Report Ear, Nose & Throat Journal 14 A Rare Nasopharyngeal

persistence of ban2401 mediated
Persistence of BAN2401-Mediated

Persistence of BAN2401-Mediated Amyloid Reductions Post-Treatment: A

simulating 1 d amyloid co polymerization
Simulating 1-D Amyloid Co-

Simulating 1-D Amyloid Co- polymerization KSU REU Noeloikeau Charlot Dr.

amyloidosis
AMYLOIDOSIS Corporation and Millennium

2/27/2014 Disclosures for Ann McNeill Consultant / Advisor for Celgene

emm1 invasive group a streptococcus
emm1 invasive Group A Streptococcus

#O226 Genome-wide longitudinal analysis of emm1 invasive Group A Streptococcus

eu regulatory perspective on the potential use of
EU regulatory perspective on the

EU regulatory perspective on the potential use of biomarkers in AD drug

developing xanamem
Developing Xanamem Presented by,

Developing Xanamem Presented by, Dr. Bill Ketelbey CEO & Managing

cor388 a novel gingipain inhibitor decreases
COR388, A NOVEL GINGIPAIN INHIBITOR,

COR388, A NOVEL GINGIPAIN INHIBITOR, DECREASES FRAGMENTATION OF APOE IN